A comprehensive view of merck & co. inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck receives positive EU CHMP opinion for KEYTRUDA and Padcev for first-line treatment of unresectable or metastatic urothelial carcinoma; based on Phase 3 KEYNOTE-A39 trial results
Published: July 26, 2024 by Merck & Co. Inc.
Merck Announces Fourth-Quarter 2024 Dividend
Published: July 23, 2024 by Merck & Co. Inc.
Merck reports successful Phase 2b/3 results for clesrovimab in preventing RSV in infants; clesrovimab met primary safety and efficacy endpoints, reducing respiratory infections through Day 150
Published: July 23, 2024 by Merck & Co. Inc.
Merck Sharp & Dohme LLC and Pfizer Inc Granted Patent for Methods of Treating or Reducing the Risk of Cardiovascular Events and Related Diseases Using SGLT-2 Inhibitors
Published: July 20, 2024 by Medical Patent News
EcoVadis SAS boosts sustainability in supply chains, gaining industry-wide recognition; key clients like Merck and CEF report business growth and enhanced environmental impact
Published: July 19, 2024 by Industry Intelligence Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count